These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 14271446)

  • 41. [INTOLERANCE AND TOXICITY OF SUBSTITUTE ANTIBACTERIAL DRUGS].
    BEK E
    Gruzlica (1926); 1963 Jun; 31():645-51. PubMed ID: 14119445
    [No Abstract]   [Full Text] [Related]  

  • 42. [ON SIDE EFFECTS IN THE TREATMENT OF TUBERCULOSIS WITH VARIOUS ISONICOTINIC ACID DERIVATIVES].
    KHAIKIN AIa
    Probl Tuberk; 1964; 42():85-7. PubMed ID: 14175081
    [No Abstract]   [Full Text] [Related]  

  • 43. Prevalence and interaction of hepatitis B and latent tuberculosis in Vietnamese immigrants to the United States.
    Patel PA; Voigt MD
    Am J Gastroenterol; 2002 May; 97(5):1198-203. PubMed ID: 12014728
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [ON HEPATITIS IN PULMONARY TUBERCULOSIS PATIENTS].
    ZADOR A; NAGY G; GEVICSER P; KLIMENKO O
    Tuberk Tudobetegsegek; 1963; 16():147-9. PubMed ID: 14054916
    [No Abstract]   [Full Text] [Related]  

  • 45. BIOCHEMICAL STUDIES OF SEVERE LIVER DAMAGE CAUSED BY P-AMINOSALICYLIC ACID.
    WATTS C; GRIFFITHS HE
    Gastroenterology; 1964 Mar; 46():317-21. PubMed ID: 14132345
    [No Abstract]   [Full Text] [Related]  

  • 46. Clinical inquiries. Are liver function tests required for patients taking isoniazid for latent TB?
    Brown MO; Howard E; DeAlleaume L
    J Fam Pract; 2004 Jan; 53(1):63-5, 68. PubMed ID: 14709272
    [No Abstract]   [Full Text] [Related]  

  • 47. CHEMOTHERAPY OF TUBERCULOSIS: A BACTERIOLOGIST'S VIEWPOINT.
    MITCHISON DA
    Br Med J; 1965 May; 1(5446):1333-40. PubMed ID: 14278838
    [No Abstract]   [Full Text] [Related]  

  • 48. [Viral and drug-induced liver damage in children with tuberculosis: prevalence, clinical features].
    Borzakova SN; Aksenova VA; Reĭzis AR
    Eksp Klin Gastroenterol; 2013; (1):38-43. PubMed ID: 23951897
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CHEMOTHERAPY OF TUBERCULOSIS.
    ROE FJ; BOYLAND E; HADDOW A
    Br Med J; 1965 Jun; 1(5449):1550. PubMed ID: 14288112
    [No Abstract]   [Full Text] [Related]  

  • 50. HYPERSENSITIVITY TO PARA-AMINOSALICYLIC ACID: A HAZARD IN THE TREATMENT OF ORTHOPAEDIC TUBERCULOSIS.
    GRIFFITHS HE; WATTS C
    J Bone Joint Surg Br; 1965 Feb; 47():86-90. PubMed ID: 14296251
    [No Abstract]   [Full Text] [Related]  

  • 51. [Effectiveness and problems of PZA-containing 6-month regimen for the treatment of new pulmonary tuberculosis patients].
    Wada M
    Kekkaku; 2001 Jan; 76(1):33-43. PubMed ID: 11211781
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [CLINICAL AND EXPERIMENTAL RESEARCH ON HYPERCORTICISM CAUSED BY ISONIAZID DURING PULMONARY TUBERCULOSIS].
    CARBONERA P; CLINI V; RIMOLDI R; TANSINI G
    G Ital Chemioter; 1964; 11():47-74. PubMed ID: 14194331
    [No Abstract]   [Full Text] [Related]  

  • 53. Ambulatory management of tuberculosis.
    Hampton JR; Bates JH
    Am Fam Physician; 1974 Nov; 10(5):204-10. PubMed ID: 4214055
    [No Abstract]   [Full Text] [Related]  

  • 54. [INFLUENCE OF SOME ANTITUBERCULAR DRUGS ON THE ALDOLASE ACTIVITIES OF THE BLOOD, LIVER AND MUSCLES OF RATS].
    VITOLO A
    Acta Vitaminol; 1963 Dec; 17():269-73. PubMed ID: 14123377
    [No Abstract]   [Full Text] [Related]  

  • 55. [Adverse effect other than liver dysfunction in treatment of latent tuberculous infection by isoniazid].
    Ito K; Hoshino H; Nakazono T; Masuyama H; Sugita H; Yoshiyama T; Kato S
    Kekkaku; 2007 Jan; 82(1):1-9. PubMed ID: 17310776
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [USE OF PYRIDOXINE IN THE TREATMENT OF SIDE EFFECTS OF ANTITUBERCULAR AGENTS].
    REZNIK SE; VILDERMAN AM
    Probl Tuberk; 1963; 41():76-7. PubMed ID: 14150240
    [No Abstract]   [Full Text] [Related]  

  • 57. [MORFAZINAMIDE IN THE TREATMENT OF PULMONARY TUBERCULOSIS].
    JIMENEZ M; VILLALBA J; KARAM J
    Gac Med Mex; 1965 Jul; 95():661-5. PubMed ID: 14345388
    [No Abstract]   [Full Text] [Related]  

  • 58. Liver function tests during treatment of tuberculosis with short-course regimens containing isoniazid, rifampicin & pyrazinamide.
    Swamy R; Acharyulu GS; Duraipandian M; Jawahar MS; Ramachandran R; Sarma GR
    Indian J Med Res; 1987 Nov; 86():549-57. PubMed ID: 3451899
    [No Abstract]   [Full Text] [Related]  

  • 59. [PRESENT-DAY KNOWLEDGE OF HEPATOTOXICITY].
    OSUGA T; KANETAKA T
    Saishin Igaku; 1965 Jan; 20():36-48. PubMed ID: 14319014
    [No Abstract]   [Full Text] [Related]  

  • 60. [NEW COMBINATIONS OF ANTITUBERCULAR AGENTS IN THE TREATMENT OF RENAL TUBERCULOSIS].
    SZENDROEI Z; CSERNUS A
    Magy Seb; 1964 Apr; 17():124-7. PubMed ID: 14152677
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.